Rifaximin Versus Placebo in the Prevention of Travelers' Diarrhea
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of poorly absorbed rifaximin in
the prevention of travelers' diarrhea among U.S. college students in Mexico for five weeks.
Phase:
Phase 2
Details
Lead Sponsor:
DuPont, Hurbert L., MD
Collaborators:
Bausch Health Americas, Inc. The University of Texas Health Science Center, Houston Valeant Pharmaceuticals International, Inc.